← Eichor
Condition: High Risk For Bleeding Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: High Risk For Bleeding

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Nafamostat Efficacy in Phase 3 Registrational CRRT Study
NA · 10 location(s) · Talphera, Inc · NCT06150742Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding
Phase 4 · 1 location(s) · University of Florida · NCT07025148Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angiop
Phase 3 · 1 location(s) · Cardiocentro Ticino · NCT07582835Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI
NA · 14 location(s) · North Karelia Central Hospital · NCT04814212Prognosis and Antiplatelet Strategies for Patients With PCI and High Bleeding Risk:A Study Protocol
Phase N/A · 1 location(s) · West China Hospital · NCT05369442Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05577988Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation
Phase N/A · 12 location(s) · Fundación EPIC · NCT06863155Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet
NA · 1 location(s) · SUK MIN SEO · NCT07479056Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction
Phase 4 · 6 location(s) · Rikke Sorensen · NCT05262803The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study
NA · 1 location(s) · Wonju Severance Christian Hospital · NCT05874674Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding R
NA · 18 location(s) · Samsung Medical Center · NCT06742931IgIV Plus Prednisone vs High-dose Dexamethasone for ITP
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04968899Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
Phase 4 · 21 location(s) · OCEAN-SHD Study Group · NCT07125417Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gast
Phase 4 · 45 location(s) · Duk-Woo Park, MD · NCT04416581Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women At Higher Risk
Phase 3 · 1 location(s) · London School of Hygiene and Tropical Medicine · NCT05562609A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug-
NA · 1 location(s) · China National Center for Cardiovascular Diseases · NCT07230847Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC
Phase 2 · 1 location(s) · Asan Medical Center · NCT06819566Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cir
NA · 1 location(s) · Grigore T. Popa University of Medicine and Pharmacy · NCT07437755PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
Phase 4 · 8 location(s) · Chinese University of Hong Kong · NCT05582174COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial
NA · 10 location(s) · University Hospital, Bordeaux · NCT06425614Highest Efficacy of Dual Antiplatelet Therapy After Carotid Artery Stenting in High Bleeding Risk Patients
NA · 1 location(s) · Woo-Keun Seo · NCT06276374Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO
NA · 1 location(s) · Fondazione Ricerca e Innovazione Cardiovascolare ETS · NCT06535568AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positiv
Phase 3 · 42 location(s) · University Hospital, Brest · NCT05198960Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding
NA · 14 location(s) · Medtronic - MITG · NCT06188585LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients
NA · 6 location(s) · Biosensors Europe SA · NCT06657326Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant
NA · 14 location(s) · McMaster University · NCT06957366Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at H
Phase 2 · 1 location(s) · University of Michigan · NCT07217899Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura
Phase 1 · 1 location(s) · New York Medical College · NCT04323748U-CaVIT Versus Standard of Care for Prevention of Atonic Postpartum Hemorrhage After Cesarean Section in High-risk Women
NA · 1 location(s) · Christian Haslinger · NCT07019623
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.